Overview
Tesamorelin is a research-grade peptide compound that has attracted significant attention in the scientific community for its role in metabolic regulation. GHRH analogue. FDA-approved backbone compound for growth hormone secretion research.
This compound belongs to the metabolic category of research peptides and has been the subject of numerous preclinical investigations. Its unique molecular properties make it a valuable tool for researchers exploring novel therapeutic pathways.
Tesamorelin is a synthetic GHRH analogue that binds pituitary GHRH receptors, stimulating pulsatile GH release without suppressing the hypothalamic-pituitary axis. The growing body of published literature continues to expand our understanding of this compound's potential applications in laboratory settings.
Mechanism of Action
Tesamorelin is a synthetic GHRH analogue that binds pituitary GHRH receptors, stimulating pulsatile GH release without suppressing the hypothalamic-pituitary axis.
The signaling pathways activated by Tesamorelin continue to be mapped through proteomic and transcriptomic analyses. Current research focuses on identifying the specific receptor subtypes and downstream effectors responsible for the observed biological responses. Understanding these molecular interactions is critical for advancing the compound from preclinical investigation toward potential translational applications.
Research Areas
- Metabolic pathway regulation research
- Glucose homeostasis and insulin sensitivity
- Energy expenditure and lipid metabolism
- Satiety signaling mechanisms
- Metabolic flux analysis
Compound Specifications
| CAS Number | 218949-48-9 |
| Purity | ≥99% HPLC-MS verified |
| Storage | −20 °C, light-sensitive. Do not shake. |
| Category | Metabolic |
| Price | €86 |
| Format | 10mg lyophilised |
Available Formats
- 2mg vial
- 5mg vial
- 10mg vial
Dissolution
Use our dilution calculator for precise concentration calculations.